Skip to Content

Letermovir

https://www.amasa-project.eu/web/image/product.template/61555/image_1920?unique=be6aa15
Applications Letermovir acts as an orally or i.v administered cytomegalovirus terminus complex inhibitor, antiviral agent, used in the treatment of CMV infection which is prevalent in those with immunocompromised systems. References Kropeit, D. et al.: Brit. J. Clin Pharmacol., 83, 2678 (2017); Kim, E. et al.: Drugs. 78, 147 (2018);

147.42 147.42 USD 147.42

147.42

Not Available For Sale

( 0.00 / Units)

This combination does not exist.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days